Anam Razzaq
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 9
- Electrospun Nanofibers in Biomedical Applications 5
- Rehabilitation top 5%
- Wound Healing and Treatments 6
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 6
- Advancements in Transdermal Drug Delivery 2
- Molecular Medicine top 10%
-
- Nanoplatforms for cancer theranostics 7
-
- Inhalation and Respiratory Drug Delivery 4
-
- Nanoparticles: synthesis and applications 4
- Co-authors
- Haroon IqbalFarid MenaaBouzid MenaaNaveed Ullah KhanGobika ThiripuranatharBushra UzairNosheen Fatima RanaBarkat Ali Khan
- Journals
- Journal of Controlled Release (1 paper)International Journal of Pharmaceutics (1 paper)International Journal of Biological Macromolecules (4 papers)
- Partner nations
- ChinaPakistanUnited States
In The Last Decade
Anam Razzaq
30 papers receiving 742 citations
Peers
Comparison fields: 5 of 98
- Biomaterials 275
- Rehabilitation 124
- Pharmaceutical Science 74
- Molecular Medicine 44
- Complementary and alternative medicine 48
Countries citing papers authored by Anam Razzaq
This map shows the geographic impact of Anam Razzaq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anam Razzaq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anam Razzaq more than expected).
Fields of papers citing papers by Anam Razzaq
This network shows the impact of papers produced by Anam Razzaq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anam Razzaq. The network helps show where Anam Razzaq may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anam Razzaq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 6 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 10 | |
| 8 | 2024 | 13 | |
| 9 | 2024 | 13 | |
| 10 | 2024 | 22 | |
| 11 | 2024 | 15 | |
| 12 | 2024 | 7 | |
| 13 | 2024 | 6 | |
| 14 | 2023 | 20 | |
| 15 | 2023 | 6 | |
| 16 | 2023 | 1 | |
| 17 | 2022 | 31 | |
| 18 | 2022 | 22 | |
| 19 | Phytochemical and GCMS approaches to identify active constituents in Erythrina suberosa bark extract and evaluation of its therapeutic potency. | 2021 | 0 |
| 20 | 2019 | 93 |
About Anam Razzaq
Anam Razzaq is a scholar working on Biomaterials, Pharmaceutical Science and Rehabilitation, having authored 33 papers that have together received 749 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers), Wound Healing and Treatments (6 papers), Advanced Drug Delivery Systems (6 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Inhalation and Respiratory Drug Delivery (4 papers), Nanoparticles: synthesis and applications (4 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Biomaterials (275 citations), Rehabilitation (124 citations) and Pharmaceutical Science (74 citations). Anam Razzaq has collaborated with scholars based in China, Pakistan and United States. Frequent co-authors include Haroon Iqbal, Farid Menaa, Bouzid Menaa, Naveed Ullah Khan, Gobika Thiripuranathar, Bushra Uzair, Nosheen Fatima Rana, Barkat Ali Khan, Hanadi A. Almukhlifi and Udari Wijesinghe. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.